{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:39:26Z","timestamp":1768916366389,"version":"3.49.0"},"reference-count":25,"publisher":"Frontline Medical Communications, Inc.","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.sder.2011.11.002","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T12:25:56Z","timestamp":1323951956000},"page":"S14-S18","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S","title":["Emerging Treatments and Signaling Pathway Inhibitors"],"prefix":"10.12788","volume":"30","author":[{"given":"Jean Y.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashfaq A.","family":"Marghoob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2011.11.002_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.11.002_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1524-4725.2003.29156.x","article-title":"Metastatic basal cell carcinoma","volume":"29","author":"Spates","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2011.11.002_bib4","series-title":"Cancer of the Skin","first-page":"73","article-title":"Chemoprevention of skin cancers","author":"Demierre","year":"2011"},{"key":"10.1016\/j.sder.2011.11.002_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1346-8138.1992.tb03766.x","article-title":"Chemoprevention of skin cancer in xeroderma pigmentosum","volume":"19","author":"Kraemer","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.sder.2011.11.002_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1529-8019.2006.00088.x","article-title":"Skin cancer chemoprevention with systemic retinoids: An adjunct in the management of selected high-risk patients","volume":"19","author":"Campbell","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2011.11.002_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/21.7.1271","article-title":"Retinoids in chemoprevention and differentiation therapy","volume":"21","author":"Hansen","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.sder.2011.11.002_bib8","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.88.14.6092","article-title":"Retinoic acid is a negative regulator of AP-1-responsive genes","volume":"88","author":"Sch\u00fcle","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sder.2011.11.002_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archdermatol.2008.542","article-title":"Topical tretinoin therapy and all-cause mortality","volume":"145","author":"Weinstock","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.11.002_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones: Mechanism of action and therapeutic potential","volume":"27","author":"Stanley","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.11.002_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.sder.2011.11.002_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/dji207","article-title":"Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment","volume":"15","author":"Urosevic","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.sder.2011.11.002_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1067\/mjd.2002.126215","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study","volume":"47","author":"Geisse","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.11.002_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1524-4725.2004.30116.x","article-title":"Topical imiquimod treatment for nodular basal cell carcinomas: An open-label series","volume":"30","author":"Huber","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2011.11.002_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaad.2007.05.022","article-title":"A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma","volume":"57","author":"Eigentler","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.11.002_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.det.2006.09.011","article-title":"Chemo-preventative thoughts for photodynamic therapy","volume":"25","author":"Bissonnette","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.sder.2011.11.002_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1011-1344(01)00246-9","article-title":"Effect of xenographic repair enzymes on photoimmunology and photocarcinogenesis","volume":"65","author":"Stege","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.sder.2011.11.002_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0781.1995.tb00130.x","article-title":"Reduction of ultraviolet-induced skin cancer in mice by topical application of DNA excision repair enzymes","volume":"1","author":"Bito","year":"1995","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.sder.2011.11.002_bib19","first-page":"4227","article-title":"Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice","volume":"52","author":"Yarosh","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.sder.2011.11.002_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(00)04214-8","article-title":"Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: A randomized study","volume":"357","author":"Yarosh","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.11.002_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","article-title":"Human homolog of patched, a candidate gene for the basal cell nevus syndrome","volume":"272","author":"Johnson","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.sder.2011.11.002_bib22","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.96.9.5117","article-title":"High levels of patched gene mutations in basal cell carcinomas in patients with xeroderma pigmentosum","volume":"96","author":"Bodak","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sder.2011.11.002_bib23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the Hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.11.002_bib24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1101\/gad.1025302","article-title":"Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened","volume":"16","author":"Chen","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.sder.2011.11.002_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.11.002_bib26","series-title":"Presented at: 69th Annual Meeting of the American Academy of Dermatology","article-title":"An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients","author":"Tang","year":"2011"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911001933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911001933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T11:23:58Z","timestamp":1497957838000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1085562911001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1085562911001933"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2011.11.002","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}